Alaunos Therapeutics, Inc.

Contributing Author

Recent Articles by Alaunos Therapeutics, Inc.

Mar-02	Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders TCRT GlobeNewswire
Jun-23	Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering TCRT GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information